Global Custom Market Research Reports Provider Company

phone

Stemline Therapeutics, Inc. (STML) - Financial and Strategic SWOT Analysis Review

  • Published Date: 01 Feb 2015
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: United States of America

Summary

Stemline Therapeutics, Inc. (Stemline) is a clinical stage biopharmaceutical company. The company develops oncology compounds, which targets both cancer stem cells (CSC’s) and the tumor bulk. Its products pipeline includes SL-301, SL-101, SL-201, SL-501 and SL-601. The company is also developing two clinical stage products SL-401 and SL-701. Its product SL-401 is a targeted therapy intended for to the interleukin-3 receptor (IL-3R). SL-701 is administered therapeutic cancer vaccine comprised of multiple synthetic peptides. Stemline’s products are used to treat blastic plasmacytoid cell neoplasm, acute myeloid leukemia, and pediatric brain cancers. Stemline is headquartered in New York, the US.

Stemline Therapeutics, Inc. Key Recent Developments

Dec 05, 2013: Stemline Therapeutics to Present at the Oppenheimer 24th Annual Healthcare Conference
Sep 19, 2013: Stemline Therapeutics to Present at the Aegis Capital Corporation 2013 Healthcare Conference
Sep 04, 2013: Stemline Therapeutics to Present at the 15th Annual Rodman & Renshaw Global Investment Conference
Aug 07, 2013: Stemline Therapeutics to Present at the 2013 Wedbush Life Sciences Conference
Jul 03, 2013: Stemline Therapeutics to Present at the JMP Securities Healthcare Conference

This comprehensive SWOT profile of Stemline Therapeutics, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Stemline Therapeutics, Inc. including: and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief Summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Publisher Name : GlobalData

Section 1 - About the Company

Stemline Therapeutics, Inc. - Key Information
Stemline Therapeutics, Inc. - Overview
Stemline Therapeutics, Inc. - Key Employees
Stemline Therapeutics, Inc. - Key Employee Biographies
Stemline Therapeutics, Inc. - Key Operational Heads
Stemline Therapeutics, Inc. - Major Products and Services
Stemline Therapeutics, Inc. - History
Stemline Therapeutics, Inc. - Company Statement
Stemline Therapeutics, Inc. - Locations And Subsidiaries
Stemline Therapeutics, Inc. - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Stemline Therapeutics, Inc. - Business Description
Stemline Therapeutics, Inc. - Corporate Strategy
Stemline Therapeutics, Inc. - SWOT Analysis
SWOT Analysis - Overview
Stemline Therapeutics, Inc. - Strengths
Stemline Therapeutics, Inc. - Weaknesses
Stemline Therapeutics, Inc. - Opportunities
Stemline Therapeutics, Inc. - Threats
Stemline Therapeutics, Inc. - Key Competitors

Section 3 - Company Financial Performance Charts

Stemline Therapeutics, Inc. - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company



List Of Tables

Stemline Therapeutics, Inc., Key Information
Stemline Therapeutics, Inc., Key Ratios
Stemline Therapeutics, Inc., Share Data
Stemline Therapeutics, Inc., Major Products and Services
Stemline Therapeutics, Inc., History
Stemline Therapeutics, Inc., Key Employees
Stemline Therapeutics, Inc., Key Employee Biographies
Stemline Therapeutics, Inc., Key Operational Heads
Stemline Therapeutics, Inc., Other Locations
Stemline Therapeutics, Inc., Subsidiaries
Stemline Therapeutics, Inc., Key Manufacturing facilities
Stemline Therapeutics, Inc., Key Competitors
Stemline Therapeutics, Inc., SWOT Analysis
Stemline Therapeutics, Inc., Ratios based on current share price
Stemline Therapeutics, Inc., Annual Ratios
Stemline Therapeutics, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios



List Of Figures

Stemline Therapeutics, Inc., Performance Chart
Stemline Therapeutics, Inc., Ratio Charts



Stemline Therapeutics Inc (Stemline) is a clinical stage biopharmaceutical company that develops therapeutics to treat cancer stem cells and tumor bulk. The company has developed discovery platform StemScreen to identify

View Report

Stemline Therapeutics Inc (Stemline) is a clinical stage biopharmaceutical company that develops therapeutics to treat cancer stem cells and tumor bulk. The company has developed discovery platform StemScreen to identify

View Report

Stemline Therapeutics, Inc. (STML) - Financial and Strategic SWOT Analysis Review market research report at USD 300 and market update available at JSB Market Research.

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports